Eric Hsi, MD

About Me

I am a hematopathologist with expertise in diagnosis of hematologic malignancy, flow cytometry, and molecular diagnostics related to blood cancers. I am the coauthor of over 350 peer-reviewed manuscripts and the author of a textbook in Hematopathology, now in it's 3rd edition. My research interests include predictive and prognostic biomarkers, preclinical therapeutic target validation, and correlative science studies related to clinical trials. I have served on national committees for organizations such as the College of American Pathologists, American Society for Clinical Pathology, ALLIANCE for Clinical Trials in Oncology, the American Society for Hematology, and the Society for Hematopathology. I have served on scientific advisory boards/panels for organizations such as the Lymphoma Research Foundation.

I received my MD at the University of Michigan, where I also completed my residency in combined anatomic and clinical pathology as well was fellowships in surgical pathology and hematopathology. I served as Section Head of Hematopathology and Chair of the Department of Clinical Pathology at Cleveland Clinic before joining Wake Forest as the Chair of the Department of Pathology and Service Line Leader for Pathology and Laboratory Medicine for Atrium Health.

Research

Publications

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach. Foucar K, Bagg A, Bueso-Ramos CE, George T, Hasserjian RP, Hsi ED, Orazi A, Tam W, Wang SA, Weinberg OK, Arber DA. Am J Clin Pathol. 2023 Jun;
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Epperla N, Switchenko J, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Sawalha Y, Hill BT, Ghosh N, Park SI, Bond DA, Hamadani M, Fenske TS, Martin P, Malecek MK, Kahl BS, Flowers CR, Link BK, Kaplan LD, Inwards DJ, Feldman AL, Hsi ED, Maddocks K, Blum KA, Bartlett NL, Cerhan JR, Leonard JP, Habermann TM, Maurer MJ, Cohen JB. Blood Adv. 2023 Jun; 7(11):2287-2296.
Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOP. Nichols MM, Ondrejka SL, Patil S, Durkin L, Hill BT, Hsi ED. Leuk Lymphoma. 2023 May; :1-9.
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group. Kirtek T, Chen W, Laczko D, Bagg A, Koduru P, Foucar K, Venable E, Nichols M, Rogers HJ, Tam W, Orazi A, Hsi ED, Hasserjian RP, Wang SA, Arber DA, Weinberg OK. Leuk Res. 2023 Jul; 130:107309.
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Li Y, Xu-Monette ZY, Abramson J, Sohani AR, Bhagat G, Tzankov A, Visco C, Zhang S, Dybkaer K, Pan Z, Xu M, Tam W, Zu Y, Hsi ED, Hagemeister FB, Go H, van Krieken JH, Winter JN, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Wang Y, Zhang M, Young KH. Blood Adv. 2023 Apr; 7(7):1308-1311.

View More Publications

More Resources

More Resources

Research Focus Areas

Translation to Care

More Resources

Eric Hsi, MD

About Me